Unknown

Dataset Information

0

Patient-derived organoids in cellulosic sponge model chemotherapy response of metastatic colorectal cancer.

ABSTRACT:

SUBMITTER: Xu Y 

PROVIDER: S-EPMC7803352 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Patient-derived organoids in cellulosic sponge model chemotherapy response of metastatic colorectal cancer.

Xu Yanjie Y   Chen Jianjun J   Huang Yizhou Y   Luo Yang Y   Hsieh An-Chih AC   Chen Jianyi J   Li Han H   Wei Xunbin X   Gao Wei-Qiang WQ   Zhong Ming M   Zhang Yan Y  

Clinical and translational medicine 20210101 1

Similar Datasets

Unknown Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer.
| S-EPMC12666313 | biostudies-literature
Unknown Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.
| S-EPMC6112415 | biostudies-literature
Unknown Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy.
| S-EPMC10202108 | biostudies-literature
Unknown Patient-Derived Organoids from Colorectal Cancer with Paired Liver Metastasis Reveal Tumor Heterogeneity and Predict Response to Chemotherapy.
| S-EPMC9631073 | biostudies-literature
Unknown Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids.
| S-EPMC9905679 | biostudies-literature
Transcriptomics Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers.
2017-12-22 | GSE108391 | GEO
Unknown Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids.
| S-EPMC8330527 | biostudies-literature
Unknown A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids.
| S-EPMC10899621 | biostudies-literature
Unknown 3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids.
| S-EPMC6576164 | biostudies-literature
Unknown High-dose short-term osimertinib treatment is effective in patient-derived metastatic colorectal cancer organoids.
| S-EPMC11523998 | biostudies-literature